Identifying pathways involved in leptin-dependent aggregation of human platelets
- 22 June 2004
- journal article
- research article
- Published by Springer Nature in International Journal of Obesity
- Vol. 28 (8) , 979-984
Abstract
OBJECTIVE: To investigate the role of phospholipase C (PLC), phospholipase A2 (PLA2), calcium, and protein kinase C (PKC) in mediating leptin-enhanced aggregation of human platelets. DESIGN: In vitro, ex vivo study. SETTING: Outpatient's Service for Prevention and Treatment of Obesity at the University Hospital of Messina, Italy. SUBJECTS: In total, 14 healthy normal-weight male (age 31.4±1.9 y; body mass index 22.7±0.6 kg/m2) subjects. MEASUREMENTS: Adenosine diphosphate-(ADP-) induced platelet aggregation and platelet free calcium were measured after incubation of platelets with leptin alone (5–500 ng/ml), or leptin (50 and 100 ng/ml) in combination with anti-human leptin receptor long form antibody (anti-ObRb-Ab, 1:800–1:100 dilutions), PLC inhibitor U73122 (3.125–25 μM), PLA2 inhibitor AACOCF3 (1.25–10 μM), or PKC inhibitor Ro31-8220 (1.25–10 μM). RESULTS: Platelet stimulation with leptin leads to a significant and dose-dependent increase in ADP-induced platelet aggregation and platelet free calcium concentrations. Leptin effects on both platelet aggregation and calcium mobilization were completely abated by the co-incubation with leptin and anti-ObRb-Ab. Leptin-induced platelet aggregation was dose-dependently inhibited by U73122, AACOCF3, or Ro31-8220. The effect of leptin on intracellular calcium was inhibited in a dose-dependent manner by incubation with U73122 and AACOCF3, but not with Ro31-8220. CONCLUSIONS: Our study confirms that leptin is able to enhance ADP-induced aggregation of human platelets, and raise the possibility that PLC, PKC, PLA2, and calcium could play a relevant role in mediating the proaggregating action of leptin.Keywords
This publication has 33 references indexed in Scilit:
- Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS)Circulation, 2001
- Leptin Inhibits Bone Formation through a Hypothalamic RelayCell, 2000
- Biological Action of Leptin as an Angiogenic FactorScience, 1998
- Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppressionNature, 1998
- CARDIOVASCULAR CONSEQUENCES OF OBESITY: ROLE OF LEPTINClinical and Experimental Pharmacology and Physiology, 1998
- Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptinNature Genetics, 1996
- Abnormal splicing of the leptin receptor in diabetic miceNature, 1996
- Identification and expression cloning of a leptin receptor, OB-RCell, 1995
- Recombinant Mouse OB Protein: Evidence for a Peripheral Signal Linking Adiposity and Central Neural NetworksScience, 1995
- Positional cloning of the mouse obese gene and its human homologueNature, 1994